Evidence map›Paper›PMID 21083502›Full record

ArticleStem cells and development2011

Dual roles of Oct4 in the maintenance of mouse P19 embryonal carcinoma cells: as negative regulator of Wnt/β-catenin signaling and competence provider for Brachyury induction.

Yusuke Marikawa, Dana Ann A Tamashiro, Toko C Fujita, Vernadeth B Alarcon

Open access · greenAbstract read
In one paragraph

Article in Stem cells and development, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Wnt pathway regulation of embryonic stem cell self-renewal.Cold Spring Harbor perspectives in biology · 2012
    Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yusuke MarikawaDepartment of Anatomy, Biochemistry, and Physiology, Institute for Biogenesis Research, University of Hawaii John A. Burns School of Medicine, Honolulu, HI 96813, USA. marikawa@hawaii.edu
Dana Ann A Tamashiro
Toko C Fujita
Vernadeth B Alarcon
University of Hawaiʻi at Mānoa · US

Funding

WORLDWIDE EPIDEMIOLOGY &EPIZOOTIOLOGY OF HANTAVIRUSG12RR003061 · NCRR · UNIVERSITY OF HAWAII AT MANOA · PI OSTRANDER, GARY K · 1986 to 2011
$32.3M
USING EEG COMPLEXITY AND HIGH PERFORMANCE COMPUTING TO PROFILE SLEEPP20RR016467 · NCRR · UNIVERSITY OF HAWAII AT MANOA · PI HOLMES, ERIC · 2001 to 2011
$24.5M
Transgenic Mouse, ICSI and IVF CoreP20GM103457 · NIGMS · UNIVERSITY OF HAWAII AT MANOA · PI WARD, WILLIAM S · 2012 to 2018
$12.9M
ULTRASOUND-TARGETED MICROBUBBLE DESTRUCTION IN COMBINATION WITH THE PIGGYBACP20RR024206 · NCRR · UNIVERSITY OF HAWAII AT MANOA · PI GOH, WILLIAM AI-KENG · 2008 to 2011
$8.4M
NCRR NIH HHS G12RR003061NCRR NIH HHS P20 RR024206NCRR NIH HHS P20RR024206NCRR NIH HHS P20RR16467NIGMS NIH HHS P20 GM103457
6 · The paper itself

Abstract

Transcription factor Oct4 is expressed in pluripotent cell lineages during mouse development, namely, in inner cell mass (ICM), primitive ectoderm, and primordial germ cells. Functional studies have revealed that Oct4 is essential for the maintenance of pluripotency in inner cell mass and for the survival of primordial germ cells. However, the function of Oct4 in the primitive ectoderm has not been fully explored. In this study, we investigated the role of Oct4 in mouse P19 embryonal carcinoma (EC) cells, which exhibit molecular and developmental properties similar to the primitive ectoderm, as an in vitro model. Knockdown of Oct4 in P19 EC cells upregulated several early mesoderm-specific genes, such as Wnt3, Sp5, and Fgf8, by activating Wnt/β-catenin signaling. Overexpression of Oct4 was sufficient to suppress Wnt/β-catenin signaling through its action as a transcriptional activator. However, Brachyury, a key regulator of early mesoderm development and a known direct target of Wnt/β-catenin signaling, was unable to be upregulated in the absence of Oct4, even with additional activation of Wnt/β-catenin signaling. Microarray analysis revealed that Oct4 positively regulated the expression of Tdgf1, a critical component of Nodal signaling, which was required for the upregulation of Brachyury in response to Wnt/β-catenin signaling in P19 EC cells. We propose a model that Oct4 maintains pluripotency of P19 EC cells through 2 counteracting actions: one is to suppress mesoderm-inducing Wnt/β-catenin signaling, and the other is to provide competence to Brachyury gene to respond to Wnt/β-catenin signaling.

Indexed as

Signal TransductionAnimalsbeta CateninBone Morphogenetic Protein 4Brachyury ProteinCell DifferentiationCell LineCell NucleusDexamethasoneEmbryonal Carcinoma Stem CellsEpidermal Growth FactorFetal ProteinsGene Expression Regulation, DevelopmentalHumansMembrane GlycoproteinsMesodermbeta CateninBone Morphogenetic Protein 4Brachyury ProteinDexamethasoneEpidermal Growth FactorFetal ProteinsMembrane GlycoproteinsNeoplasm ProteinsOctamer Transcription Factor-3Peptide FragmentsPou5f1 protein, mouseRecombinant Fusion ProteinsT-Box Domain ProteinsTdgf1 protein, mouseWnt Proteins

Identifiers

PMID21083502
PMCPMC3112048
OpenAlexW2051104316

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.